의료용 가스 및 장비 시장 : 유형별(의료용 가스(산소, 아산화질소), 의료용 가스 장비(유량계, 기타)), 용도별(치료, 진단), 최종사용자별(병원, 재택의료) - 세계 예측(-2031년)

The global medical gas and equipment market is projected to reach USD 30.05 billion by 2031 from USD 21.03 billion in 2025, at a CAGR of 6.2% during the forecast period.

The medical gas and equipment market is witnessing consistent growth. This is largely due to increased demand for respiratory care, critical care, and surgical procedures across healthcare systems worldwide. The rising prevalence of chronic diseases such as COPD, asthma, and cardiovascular disorders, along with a growing elderly population, has significantly increased dependence on medical gases and related delivery equipment. Moreover, the development and refurbishment of hospital buildings, ambulatory surgical centers, and home healthcare services, especially in developing countries, are leading to new medical gas infrastructure installations and upgrades. Furthermore, innovations in gas delivery systems, portable devices, and monitoring solutions are revolutionizing treatment efficiency and making care more accessible. Together, these factors are driving continued growth in the medical gas and equipment market.

"By type, the medical gases segment is expected to have the largest market share in the medical gas and equipment market."

Medical gases represent the largest segment in the medical gas and equipment market by type, owing to their indispensable and constant use across nearly all healthcare settings. Gases such as oxygen, medical air, nitrous oxide, nitrogen, and carbon dioxide play a vital role in respiratory therapy, anesthesia, intensive care, emergency treatment, and a wide range of diagnostic and therapeutic procedures. While equipment is purchased or replaced on a one-time basis, medical gases are consumables that require a regular supply; hence, demand for them is consistently high. The escalating number of chronic disease cases, increasing surgical procedures, and rising hospital and ICU admissions continue to fuel medical gas consumption. Furthermore, the growth of home healthcare and long-term oxygen therapy, coupled with stringent regulatory requirements that guarantee uninterrupted gas availability in healthcare facilities, are among the reasons medical gases still hold the largest share of the overall medical gas and equipment market.

"By application, the therapeutic applications segment is expected to have the largest market share in the medical gas and equipment market."

Therapeutic uses account for the largest share of the application segment in the medical gas and equipment market, as medical gases are of prime importance to the treatment and management of various acute and chronic conditions. Oxygen, nitrous oxide, and medical air are used in almost all cases of respiratory therapy, critical care, emergency medicine, anesthesia, and pain management, making them essential equipment in hospitals, clinics, and home care. With the rise in the number of people suffering from chronic respiratory and cardiovascular diseases, along with the increase in the elderly population, there has been a consequent demand for long-term, continuous therapeutic gas administration. In addition, more hospital admissions, higher surgical volumes, and the expanded use of home healthcare and long-term oxygen therapy further support the prominence of therapeutic applications. Consequently, the continuous, large-scale use of medical gases for patient treatment continues to drive the leading share of this segment in the medical gas and equipment market.

"The US is expected to grow at the highest CAGR for the North America medical gas and equipment market."

The US market for medical gases and equipment is projected to have the highest CAGR in North America, driven by advanced healthcare infrastructure and high healthcare spending. Rising chronic respiratory and cardiovascular illnesses and an aging population are major factors behind substantial demand for medical gases such as oxygen and their delivery equipment. In addition, increased hospitalizations, growth in ICU facilities, and rising surgical volumes are accelerating the installation and upgrades of medical gas pipeline systems and equipment. The boom in home healthcare and the long-term oxygen therapy market, along with stringent patient safety regulations and compliance requirements, are propelling the market to grow faster. On top of that, ongoing technological progress and the presence of prominent medical gas manufacturers and service providers in the U.S. are helping the country maintain its position as the fastest-growing market in North America.

A breakdown of the primary participants (supply-side) for the medical gas and equipment market referred to for this report is provided below:

• By Company Type: Tier 1-35%, Tier 2-40%, and Tier 3-25%
• By Designation: C-level-45%, Director Level-35%, and Others-20%
• By Region: North America-27%, Europe-25%, Asia Pacific-30%, Latin America- 8%, Middle East & Africa-10% .

Prominent players in the medical gas and equipment market are Air Liquide (France), Linde Plc (Germany), Taiyo Nippon Sanso Corporation (Japan), Air Products and Chemicals Inc. (US), Atlas Copco AB (Sweden), GCE Group (Sweden), Messer SE & Co. KGaA (Germany), SOL Spa (Italy), Rotarex (Europe), Norco Inc. (US), Genstar Technologies (US), Southern Gas Limited (India), Calox Inc. (US), Ellenbarrie Industrial Gases (India), Steelman Gases Pvt. Ltd. (India), Butler Gas Products Company (US), SCI Analytical (US), Amico Group of Companies (US), Oxygen & Argon Works Ltd. (Israel), AOPL (India), Apex Medical Gas Inc. (US).

Research Coverage:

The report analyzes the medical gas and equipment market and aims to estimate the market size and future growth potential across various segments, including type, application, end user, and region. The report also includes a competitive analysis of the key players in this market, along with their company profiles, service offerings, recent developments, and key market strategies.

Reasons to Buy the Report

The report will provide market leaders and new entrants in this market with the closest available estimates of revenue for the overall medical gas and equipment market. It will help stakeholders understand the competitive landscape and gain insights to position their businesses more effectively and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides information on key market drivers, restraints, challenges, and opportunities.

This report provides insights into the following pointers:

• Analysis of key drivers (rising demand for medical oxygen, increasing number of surgeries, growing elderly population, and rising demand for home healthcare), restraints (declining reimbursements for respiratory therapies, and global helium shortage), opportunities (expansion of healthcare industry, rising demand for pain management, and advancements in healthcare technology) and challenges (limited availability of medical gases, and high cost of medical gas equipment).
• Market Penetration: It includes extensive information on products offered by the major players in the global the medical gas and equipment market. The report includes various segments in type, application, end user and region.
• Product Enhancement/Innovation: Comprehensive details about new product launches and anticipated trends in the global medical gas and equipment market.
• Market Development: Thorough knowledge and analysis of the profitable rising markets by offering, application, end user and region.
• Market Diversification: Comprehensive information about newly launched products, expanding markets, current advancements, and investments in the global the medical gas and equipment market.
• Competitive Assessment: Thorough evaluation of the market shares, growth plans, offerings of products, and capacities of the major competitors in the global medical gas and equipment market.

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
• 1.3 STUDY SCOPE
  • 1.3.1 MARKET SEGMENTATION & REGIONAL SCOPE
  • 1.3.2 INCLUSIONS & EXCLUSIONS
  • 1.3.3 YEARS CONSIDERED
  • 1.3.4 CURRENCY CONSIDERED
• 1.4 STAKEHOLDERS
• 1.5 SUMMARY OF CHANGES

2 EXECUTIVE SUMMARY

• 2.1 KEY INSIGHTS & MARKET HIGHLIGHTS
• 2.2 KEY MARKET PARTICIPANTS: INSIGHTS & DEVELOPMENTS
• 2.3 DISRUPTIVE TRENDS SHAPING MARKET GROWTH
• 2.4 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS
• 2.5 SNAPSHOT: GLOBAL MARKET SIZE, GROWTH RATE, AND FORECAST

3 PREMIUM INSIGHTS

• 3.1 MEDICAL GAS AND EQUIPMENT MARKET OVERVIEW
• 3.2 ASIA PACIFIC MEDICAL GAS AND EQUIPMENT MARKET
• 3.3 MEDICAL GAS AND EQUIPMENT MARKET: REGIONAL MIX
• 3.4 MEDICAL GAS AND EQUIPMENT MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES
• 3.5 MEDICAL GAS AND EQUIPMENT MARKET: DEVELOPING VS. DEVELOPED MARKETS

4 MARKET OVERVIEW

• 4.1 INTRODUCTION
• 4.2 MARKET DYNAMICS
  • 4.2.1 DRIVERS
    • 4.2.1.1 Increasing demand for medical oxygen
    • 4.2.1.2 Growing number of surgeries
    • 4.2.1.3 Expansion of geriatric population and subsequent rise in chronic diseases
    • 4.2.1.4 Shift toward home healthcare settings
  • 4.2.2 RESTRAINTS
    • 4.2.2.1 Declining reimbursements for respiratory therapies
    • 4.2.2.2 Strict regulatory and safety compliance requirements
  • 4.2.3 OPPORTUNITIES
    • 4.2.3.1 Expansion of healthcare industry
    • 4.2.3.2 Surge in demand for pain management solutions
    • 4.2.3.3 Growing advancements in healthcare technologies
  • 4.2.4 CHALLENGES
    • 4.2.4.1 Limited availability of medical gases
    • 4.2.4.2 High cost of medical gas equipment
• 4.3 UNMET NEEDS & WHITE SPACES
  • 4.3.1 UNMET NEEDS IN MEDICAL GAS AND EQUIPMENT MARKET
  • 4.3.2 WHITE SPACE OPPORTUNITIES
• 4.4 INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES
  • 4.4.1 INTERCONNECTED MARKETS
  • 4.4.2 CROSS-SECTOR OPPORTUNITIES
• 4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS

5 INDUSTRY TRENDS

• 5.1 PORTER'S FIVE FORCES ANALYSIS
  • 5.1.1 THREAT OF NEW ENTRANTS
  • 5.1.2 THREAT OF SUBSTITUTES
  • 5.1.3 BARGAINING POWER OF SUPPLIERS
  • 5.1.4 BARGAINING POWER OF BUYERS
  • 5.1.5 INTENSITY OF COMPETITIVE RIVALRY
• 5.2 MACROECONOMIC OUTLOOK
  • 5.2.1 INTRODUCTION
  • 5.2.2 GDP TRENDS & FORECAST
  • 5.2.3 TRENDS IN RESPIRATORY CARE DEVICES INDUSTRY
  • 5.2.4 TRENDS IN MEDICAL NITROUS OXIDE INDUSTRY
• 5.3 SUPPLY CHAIN ANALYSIS
• 5.4 VALUE CHAIN ANALYSIS
• 5.5 ECOSYSTEM ANALYSIS
• 5.6 PRICING ANALYSIS
  • 5.6.1 AVERAGE SELLING PRICE TREND OF MEDICAL GASES, BY KEY PLAYER (2023-2025)
  • 5.6.2 AVERAGE SELLING PRICE TREND OF MEDICAL GASES AND EQUIPMENT, BY REGION (2023-2025)
• 5.7 TRADE DATA ANALYSIS
  • 5.7.1 IMPORT DATA
  • 5.7.2 EXPORT DATA
• 5.8 KEY CONFERENCES & EVENTS, 2026-2027
• 5.9 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
• 5.10 INVESTMENT & FUNDING SCENARIO
• 5.11 CASE STUDY ANALYSIS
  • 5.11.1 CASE STUDY 1: ADOPTION OF COMPUTERIZED TRACKING SYSTEM FOR IMPROVED PATIENT SAFETY AND STREAMLINED COMPLIANCE DOCUMENTATION
  • 5.11.2 CASE STUDY 2: IMPLEMENTATION OF COMPREHENSIVE ALARM MANAGEMENT SYSTEM FOR RESPONSIBLE SURVEILLANCE
  • 5.11.3 CASE STUDY 3: DEVELOPMENT OF PRESSURE SWING ADSORPTION PLANTS TO MEET INCREASING NEEDS OF LIQUID MEDICAL OXYGEN
• 5.12 IMPACT OF 2025 US TARIFFS ON MEDICAL GAS AND EQUIPMENT MARKET
  • 5.12.1 INTRODUCTION
  • 5.12.2 KEY TARIFF RATES
  • 5.12.3 PRICE IMPACT ANALYSIS
  • 5.12.4 IMPACT ON COUNTRY/REGION
    • 5.12.4.1 US
    • 5.12.4.2 Europe
    • 5.12.4.3 Asia Pacific
    • 5.12.4.4 Latin America
    • 5.12.4.5 Middle East & Africa/GCC
  • 5.12.5 IMPACT ON END USER INDUSTRIES

6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS

• 6.1 KEY EMERGING TECHNOLOGIES
  • 6.1.1 SMART MEDICAL GAS MONITORING SYSTEMS
  • 6.1.2 AI-BASED PREDICTIVE MAINTENANCE
  • 6.1.3 DIGITAL TWIN TECHNOLOGY
• 6.2 COMPLEMENTARY TECHNOLOGIES
  • 6.2.1 MEDICAL GAS PIPELINE SYSTEMS (MGPS)
• 6.3 ADJACENT TECHNOLOGIES
  • 6.3.1 HEALTHCARE IOT (IOMT)
• 6.4 TECHNOLOGY/PRODUCT ROADMAP
  • 6.4.1 SHORT TERM (2025-2027) | FOUNDATION & EARLY COMMERCIALIZATION
  • 6.4.2 MID TERM (2027-2030) | EXPANSION & STANDARDIZATION
  • 6.4.3 LONG TERM (2030-2035+) | MASS COMMERCIALIZATION & DISRUPTION
• 6.5 PATENT ANALYSIS
• 6.6 FUTURE APPLICATIONS OF MEDICAL GAS AND EQUIPMENT
• 6.7 IMPACT OF AI/GEN AI ON MEDICAL GAS AND EQUIPMENT MARKET
  • 6.7.1 TOP USE CASES & MARKET POTENTIAL
  • 6.7.2 BEST PRACTICES IN MEDICAL GAS AND EQUIPMENT PROCESSING
  • 6.7.3 CASE STUDIES OF AI IMPLEMENTATION IN MEDICAL GAS AND EQUIPMENT MARKET
  • 6.7.4 INTERCONNECTED ADJACENT ECOSYSTEMS & IMPACT ON MARKET PLAYERS
  • 6.7.5 CLIENTS' READINESS TO ADOPT GENERATIVE AI IN MEDICAL GAS AND EQUIPMENT MARKET

7 REGULATORY LANDSCAPE

• 7.1 REGIONAL REGULATIONS & COMPLIANCE
  • 7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 7.1.2 INDUSTRY STANDARDS
• 7.2 CERTIFICATIONS, LABELING, AND ECO-STANDARDS

8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR

• 8.1 DECISION-MAKING PROCESS
• 8.2 BUYER STAKEHOLDERS & BUYING EVALUATION CRITERIA
  • 8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • 8.2.2 BUYING CRITERIA
• 8.3 ADOPTION BARRIERS & INTERNAL CHALLENGES
• 8.4 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES
• 8.5 MARKET PROFITABILITY
  • 8.5.1 REVENUE POTENTIAL
  • 8.5.2 COST DYNAMICS
  • 8.5.3 MARGIN OPPORTUNITIES IN KEY APPLICATIONS

9 MEDICAL GAS AND EQUIPMENT MARKET, BY TYPE

• 9.1 INTRODUCTION
• 9.2 MEDICAL GASES
  • 9.2.1 PURE MEDICAL GASES
    • 9.2.1.1 Oxygen
      • 9.2.1.1.1 Increasing prevalence of respiratory diseases to accelerate growth
    • 9.2.1.2 Carbon dioxide
      • 9.2.1.2.1 Evolving technologies and treatment methods in healthcare sector to facilitate growth
    • 9.2.1.3 Nitrogen
      • 9.2.1.3.1 Growing utilization in reproductive medicine and regenerative medicine to drive market
    • 9.2.1.4 Nitrous oxide
      • 9.2.1.4.1 Increasing emphasis on patient comfort to contribute to market growth
    • 9.2.1.5 Medical air
      • 9.2.1.5.1 Growing need for advanced healthcare infrastructure to boost market
    • 9.2.1.6 Other pure medical gases
  • 9.2.2 MEDICAL GAS MIXTURES
    • 9.2.2.1 Blood gas mixtures
      • 9.2.2.1.1 Growing integration with electronic health records and other diagnostic systems to boost market
    • 9.2.2.2 Lung diffusion mixtures
      • 9.2.2.2.1 Rising importance of early detection and management of lung disorders to favor growth
    • 9.2.2.3 Nitrous oxide-oxygen mixtures
      • 9.2.2.3.1 Expanding role in anesthesia and pain management to sustain growth
    • 9.2.2.4 Carbon dioxide-oxygen mixtures
      • 9.2.2.4.1 Growing adoption of minimally invasive surgical techniques to propel market
    • 9.2.2.5 Laser gas mixtures
      • 9.2.2.5.1 Increasing applications in dermatology, ophthalmology, and oncology to stimulate growth
    • 9.2.2.6 Anaerobic gas mixtures
      • 9.2.2.6.1 Increasing adoption of advanced equipment in clinical and research settings to promote growth
    • 9.2.2.7 Aerobic gas mixtures
      • 9.2.2.7.1 Booming geriatric population and rising pollution levels to drive market
    • 9.2.2.8 Helium-oxygen mixtures
      • 9.2.2.8.1 Rising benefits in emergency and routine medical care to expedite growth
    • 9.2.2.9 Other medical gas mixtures
• 9.3 MEDICAL GAS EQUIPMENT
  • 9.3.1 GAS DELIVERY SYSTEMS
    • 9.3.1.1 Rising focus on patient stability and recovery to promote growth
  • 9.3.2 GAS SUPPLY EQUIPMENT
    • 9.3.2.1 Medical gas cylinders
      • 9.3.2.1.1 Growing demand for portable oxygen delivery and emergency medical preparedness to propel market
    • 9.3.2.2 Bulk storage systems
      • 9.3.2.2.1 Rising healthcare infrastructure expansion and increasing medical gas consumption to propel market
    • 9.3.2.3 Liquid oxygen systems
      • 9.3.2.3.1 Increasing demand for high-volume oxygen supply and critical care services to propel market
    • 9.3.2.4 Cryogenic tanks
      • 9.3.2.4.1 Growing adoption of centralized medical gas storage and rising demand for large-capacity gas reserves to propel market
    • 9.3.2.5 Vacuum systems
      • 9.3.2.5.1 Growing focus on infection control and complex surgical therapies to propel market
    • 9.3.2.6 Medical air compressors
      • 9.3.2.6.1 Increasing demand for advanced healthcare services to augment growth
  • 9.3.3 GAS REGULATION & MONITORING EQUIPMENT
    • 9.3.3.1 Regulators
      • 9.3.3.1.1 Rising focus on treatment efficacy and patient safety to augment growth
    • 9.3.3.2 Flowmeters
      • 9.3.3.2.1 Increasing use in anesthesia, respiratory therapy, and neonatal care applications to boost market
    • 9.3.3.3 Valves with integrated pressure regulators (VIPRs)
      • 9.3.3.3.1 Rising focus on improved patient care and streamlined operations to favor growth
    • 9.3.3.4 Pressure gauges
      • 9.3.3.4.1 Increasing emphasis on medical gas safety and real-time pressure monitoring to propel market
    • 9.3.3.5 Gas monitoring systems
      • 9.3.3.5.1 Need for safe and effective delivery of medical gases to aid growth
  • 9.3.4 OTHER EQUIPMENT & ACCESSORIES

10 MEDICAL GAS AND EQUIPMENT MARKET, BY APPLICATION

• 10.1 INTRODUCTION
• 10.2 THERAPEUTIC APPLICATIONS
  • 10.2.1 RESPIRATORY THERAPIES
    • 10.2.1.1 Increasing accessibility of portable and home-based respiratory therapy equipment to boost market
  • 10.2.2 CARDIOVASCULAR THERAPIES
    • 10.2.2.1 Sedentary lifestyles and poor dietary habits to sustain growth
  • 10.2.3 ANESTHESIA DELIVERY
    • 10.2.3.1 Growing incidence of age-related health conditions to fuel market
  • 10.2.4 CRYOSURGERY APPLICATIONS
    • 10.2.4.1 Increasing demand for minimally invasive and cost-effective treatments to promote growth
  • 10.2.5 OTHER THERAPEUTIC APPLICATIONS
• 10.3 PHARMACEUTICAL MANUFACTURING & RESEARCH APPLICATIONS
  • 10.3.1 BOOMING BIOPHARMACEUTICAL RESEARCH & DEVELOPMENT INITIATIVES TO ENCOURAGE GROWTH
• 10.4 DIAGNOSTIC APPLICATIONS
  • 10.4.1 MEDICAL IMAGING
    • 10.4.1.1 Rising demand for high-resolution imaging and advanced diagnostic capabilities to propel market
  • 10.4.2 GENERAL LABORATORY APPLICATIONS
    • 10.4.2.1 Need for efficient functioning of equipment and compliance with regulatory standards to drive market
• 10.5 OTHER APPLICATIONS

11 MEDICAL GAS AND EQUIPMENT MARKET, BY END USER

• 11.1 INTRODUCTION
• 11.2 HOSPITALS & CLINICS
  • 11.2.1 BOOMING OUTPATIENT CARE AND SPECIALIZED CLINIC SERVICES TO AUGMENT GROWTH
• 11.3 HOME HEALTHCARE
  • 11.3.1 GROWING SHIFT TOWARD HOME HEALTHCARE TO SUPPORT MARKET
• 11.4 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
  • 11.4.1 ONGOING ADVANCEMENTS IN PERSONALIZED MEDICINE, GENE THERAPY, AND IMMUNOTHERAPY TO ENCOURAGE GROWTH
• 11.5 ACADEMIC & RESEARCH INSTITUTIONS
  • 11.5.1 GROWING IMPORTANCE OF HIGH-QUALITY EDUCATION AND TRAINING TO BOOST MARKET
• 11.6 OTHER END USERS

12 MEDICAL GAS AND EQUIPMENT MARKET, BY REGION

• 12.1 INTRODUCTION
• 12.2 NORTH AMERICA
  • 12.2.1 US
    • 12.2.1.1 Presence of key players to sustain growth
  • 12.2.2 CANADA
    • 12.2.2.1 Stringent regulatory compliance to favor market growth
• 12.3 EUROPE
  • 12.3.1 GERMANY
    • 12.3.1.1 Growing adoption of advanced healthcare technologies to fuel market
  • 12.3.2 UK
    • 12.3.2.1 Growing aging population to drive market
  • 12.3.3 FRANCE
    • 12.3.3.1 Well-established healthcare system to support growth
  • 12.3.4 SPAIN
    • 12.3.4.1 High burden of chronic diseases to augment growth
  • 12.3.5 ITALY
    • 12.3.5.1 Rising demand for therapeutic gases to aid growth
  • 12.3.6 REST OF EUROPE
• 12.4 ASIA PACIFIC
  • 12.4.1 JAPAN
    • 12.4.1.1 Dominant elderly population to propel market
  • 12.4.2 CHINA
    • 12.4.2.1 Strong public healthcare infrastructure to stimulate growth
  • 12.4.3 INDIA
    • 12.4.3.1 Growing incidence of cardiovascular diseases to spur growth
  • 12.4.4 AUSTRALIA
    • 12.4.4.1 Robust Medicare program to facilitate growth
  • 12.4.5 SOUTH KOREA
    • 12.4.5.1 Increasing cases of heart disease, obesity, cancer, and diabetes to drive market
  • 12.4.6 REST OF ASIA PACIFIC
• 12.5 LATIN AMERICA
  • 12.5.1 BRAZIL
    • 12.5.1.1 Increasing healthcare spending to contribute to market growth
  • 12.5.2 MEXICO
    • 12.5.2.1 Expanding pharmaceutical industry to propel market
  • 12.5.3 REST OF LATIN AMERICA
• 12.6 MIDDLE EAST & AFRICA
  • 12.6.1 FAVORABLE GOVERNMENT INITIATIVES FOR INFRASTRUCTURE DEVELOPMENT TO DRIVE MARKET
  • 12.6.2 GCC COUNTRIES
    • 12.6.2.1 Increasing prevalence of cardiovascular diseases to augment growth
  • 12.6.3 REST OF MIDDLE EAST & AFRICA

13 COMPETITIVE LANDSCAPE

• 13.1 INTRODUCTION
• 13.2 KEY PLAYER STRATEGY/RIGHT TO WIN
  • 13.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN MEDICAL GAS AND EQUIPMENT MARKET
• 13.3 REVENUE ANALYSIS, 2021-2025
• 13.4 MARKET SHARE ANALYSIS, 2025
• 13.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025
  • 13.5.1 STARS
  • 13.5.2 EMERGING LEADERS
  • 13.5.3 PERVASIVE PLAYERS
  • 13.5.4 PARTICIPANTS
  • 13.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025
    • 13.5.5.1 Company footprint
    • 13.5.5.2 Region footprint
    • 13.5.5.3 Type footprint
    • 13.5.5.4 Application footprint
    • 13.5.5.5 End-user footprint
• 13.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025
  • 13.6.1 PROGRESSIVE COMPANIES
  • 13.6.2 RESPONSIVE COMPANIES
  • 13.6.3 DYNAMIC COMPANIES
  • 13.6.4 STARTING BLOCKS
  • 13.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025
    • 13.6.5.1 Detailed list of key startups/SMEs
    • 13.6.5.2 Competitive benchmarking of startups/SMEs
• 13.7 BRAND/PRODUCT COMPARISON
• 13.8 COMPANY VALUATION & FINANCIAL METRICS
  • 13.8.1 FINANCIAL METRICS
  • 13.8.2 COMPANY VALUATION
• 13.9 COMPETITIVE SCENARIO
  • 13.9.1 DEALS
  • 13.9.2 EXPANSIONS
  • 13.9.3 THER DEVELOPMENTS

14 COMPANY PROFILES

• 14.1 KEY PLAYERS
  • 14.1.1 LINDE PLC
    • 14.1.1.1 Business overview
    • 14.1.1.2 Products offered
    • 14.1.1.3 Recent developments
      • 14.1.1.3.1 Expansions
    • 14.1.1.4 MnM view
      • 14.1.1.4.1 Right to win
      • 14.1.1.4.2 Strategic choices
      • 14.1.1.4.3 Weaknesses & competitive threats
  • 14.1.2 AIR LIQUIDE
    • 14.1.2.1 Business overview
    • 14.1.2.2 Products offered
    • 14.1.2.3 Recent developments
      • 14.1.2.3.1 Deals
      • 14.1.2.3.2 Expansions
      • 14.1.2.3.3 Other developments
    • 14.1.2.4 MnM view
      • 14.1.2.4.1 Right to win
      • 14.1.2.4.2 Strategic choices
      • 14.1.2.4.3 Weaknesses & competitive threats
  • 14.1.3 MESSER SE & CO. KGAA
    • 14.1.3.1 Business overview
    • 14.1.3.2 Products offered
    • 14.1.3.3 Recent developments
      • 14.1.3.3.1 Deals
      • 14.1.3.3.2 Expansions
    • 14.1.3.4 MnM view
      • 14.1.3.4.1 Right to win
      • 14.1.3.4.2 Strategic choices
      • 14.1.3.4.3 Weaknesses & competitive threats
  • 14.1.4 AIR PRODUCTS AND CHEMICALS, INC.
    • 14.1.4.1 Business overview
    • 14.1.4.2 Products offered
    • 14.1.4.3 MnM view
      • 14.1.4.3.1 Right to win
      • 14.1.4.3.2 Strategic choices
      • 14.1.4.3.3 Weaknesses & competitive threats
  • 14.1.5 NIPPON SANSO HOLDINGS CORPORATION
    • 14.1.5.1 Business overview
    • 14.1.5.2 Products offered
    • 14.1.5.3 Recent developments
      • 14.1.5.3.1 Deals
    • 14.1.5.4 MnM view
      • 14.1.5.4.1 Right to win
      • 14.1.5.4.2 Strategic choices
      • 14.1.5.4.3 Weaknesses & competitive threats
  • 14.1.6 ATLAS COPCO AB
    • 14.1.6.1 Business overview
    • 14.1.6.2 Products offered
    • 14.1.6.3 Recent developments
      • 14.1.6.3.1 Deals
  • 14.1.7 GCE GROUP
    • 14.1.7.1 Business overview
    • 14.1.7.2 Products offered
    • 14.1.7.3 Recent developments
      • 14.1.7.3.1 Deals
  • 14.1.8 SOL SPA
    • 14.1.8.1 Business overview
    • 14.1.8.2 Products offered
    • 14.1.8.3 Recent developments
      • 14.1.8.3.1 Deals
      • 14.1.8.3.2 Expansions
  • 14.1.9 ROTAREX
    • 14.1.9.1 Business overview
    • 14.1.9.2 Products offered
  • 14.1.10 NORCO INC.
    • 14.1.10.1 Business overview
    • 14.1.10.2 Products offered
  • 14.1.11 GENSTAR TECHNOLOGIES
    • 14.1.11.1 Business overview
    • 14.1.11.2 Products offered
  • 14.1.12 SOUTHERN GAS LIMITED
    • 14.1.12.1 Business overview
    • 14.1.12.2 Products offered
  • 14.1.13 DRAGERWERK AG & CO. KGAA
    • 14.1.13.1 Business overview
    • 14.1.13.2 Products offered
  • 14.1.14 CALOX INC.
    • 14.1.14.1 Business overview
    • 14.1.14.2 Products offered
  • 14.1.15 PT SAMATOR INDO GAS TBK
    • 14.1.15.1 Business overview
    • 14.1.15.2 Products offered
• 14.2 OTHER PLAYERS
  • 14.2.1 BUTLER GAS PRODUCTS COMPANY
  • 14.2.2 AMICO GROUP OF COMPANIES
  • 14.2.3 AIMS OXYGEN PVT LTD. (AOPL)
  • 14.2.4 APEX MEDICAL GAS INC.
  • 14.2.5 CHENGDU TAIYO INDUSTRIAL GASES CO., LTD.
  • 14.2.6 STEELMAN GASES PVT. LTD.
  • 14.2.7 CARBIDE AND CHEMICALS
  • 14.2.8 HOLSTON GASES
  • 14.2.9 MEC MEDICAL LTD.
  • 14.2.10 PRECISION UK

15 RESEARCH METHODOLOGY

• 15.1 RESEARCH DATA
  • 15.1.1 SECONDARY DATA
    • 15.1.1.1 Key data from secondary sources
  • 15.1.2 PRIMARY DATA
    • 15.1.2.1 Key data from primary sources
    • 15.1.2.2 Key industry insights
• 15.2 MARKET SIZE ESTIMATION
  • 15.2.1 BOTTOM-UP APPROACH
  • 15.2.2 TOP-DOWN APPROACH
  • 15.2.3 BASE NUMBER ESTIMATION
• 15.3 MARKET FORECAST APPROACH
• 15.4 MARKET BREAKDOWN & DATA TRIANGULATION
• 15.5 ASSUMPTIONS
  • 15.5.1 MARKET SHARE ASSUMPTIONS
  • 15.5.2 RESEARCH ASSUMPTIONS
• 15.6 FACTOR ANALYSIS
• 15.7 RISK ASSESSMENT
• 15.8 METHODOLOGY-RELATED LIMITATIONS

16 APPENDIX

• 16.1 DISCUSSION GUIDE
• 16.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 16.3 CUSTOMIZATION OPTIONS
• 16.4 RELATED REPORTS
• 16.5 AUTHOR DETAILS